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ABSTRACT
HbVar (http://globin.bx.psu.edu/hbvar) is a widely-
used locus-specific database (LSDB) launched 20
years ago by a multi-center academic effort to pro-
vide timely information on the numerous genomic
variants leading to hemoglobin variants and all types
of thalassemia and hemoglobinopathies. Here, we
report several advances for the database. We made
clinically relevant updates of HbVar, implemented as
additional querying options in the HbVar query page,
allowing the user to explore the clinical phenotype of
compound heterozygous patients. We also made sig-
nificant improvements to the HbVar front page, mak-
ing comparative data querying, analysis and output
more user-friendly. We continued to expand and en-
rich the regular data content, involving 1820 variants,
230 of which are new entries. We also increased the
querying potential and expanded the usefulness of
HbVar database in the clinical setting. These several
additions, expansions and updates should improve
the utility of HbVar both for the globin research com-
munity and in a clinical setting.
INTRODUCTION
Hemoglobinopathies are the most common single-gene ge-
netic disorders in humans, resulting from pathogenic ge-
nomic variants in the human -like and -like globin gene
clusters (1). The human -globin gene cluster is comprised
of the HBZ (OMIM# 142310), HBA2 (OMIM# 141850),
HBA1 (OMIM# 141800), HBM (OMIM# 609639) and
HBQ1 (OMIM# 142240) genes, which encode the  -, 2-,
1- and possibly - and -globin polypeptide chains, re-
spectively. The human -globin gene cluster is comprised
of the HBE1 (OMIM# 142100), HBG2 (OMIM# 142250),
HBG1 (OMIM# 142200), HBD (OMIM# 142000) and
HBB (OMIM# 141900) genes, which encode the ε-, G ,
A -, - and -globin polypeptide chains, respectively. Many
hemoglobin variants result from single nucleotide variants
or indels, leading to amino acid replacements, while delete-
rious variants in either regulatory or coding regions of the
human HBA2, HBA1, HBB or HBD genes can minimally
or drastically reduce their expression, leading to -, - or
-thalassemia respectively.
The HbVar database of hemoglobin variants and tha-
lassemia mutations is one of the oldest and most widely used
locus-specific databases (LSDBs), not only from the globin
but also from the wider genetic database community. Hb-
Var was launched 20 years ago, in 2001. It was built from
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previous compilations of variants in books (2,3), converting
this information into a publicly available LSDB to provide
timely information to interested users, e.g. the globin re-
search community, patients and their parents, and providers
of genetic services and counseling. HbVar was developed
in such a way to allow for regular data entry updates and
corrections, as new hemoglobin variants and thalassemias
continue to be discovered. In addition, with a comprehen-
sive query interface, HbVar enables the user to easily access
the stored information particularly for the research commu-
nity, but it is also an aid for physicians in diagnosis. Since
its launch, HbVar has rapidly become an important data re-
source for the globin research community and is considered
to be one of the premier LSDBs available to date (4).
Here, apart from the regular data content updates and
corrections, we report important new updates in HbVar
structure and functionality, aiming both at increasing the
impact of the database among not only the globin research
but also the clinical community, and facilitating data query-
ing and output.
UPDATES TO EXISTING DATA
Since the launch of HbVar (5) and the previous database up-
dates in 2004 (6), 2007 (7) and 2014 (8), HbVar information
has been expanded by more than 230 additional entries and
data corrections, made continually by the database cura-
tors. Importantly, Dr. Philippe Joly (Hôpital Edouard Her-
riot, Unité de Pathologie Moléculaire du Globule Rouge,
Lyon, France) and Dr Serge Pissard (Mondor Institute
of Biomedical Research, Department of Genetics, Creteil,
France) have recently joined the HbVar team as data cu-
rators. In order to identify new hemoglobin variants and
thalassemia mutations not previously documented in the
database, we manually scanned articles from the special-
ized journal Hemoglobin, which frequently publishes new
hemoglobin variants and thalassemia mutations, and where
applicable, previously undocumented variants and addi-
tional information for existing variants have been entered
into HbVar. We also benefit from continuous communica-
tion with the globin research community and independent
researchers, who provide information and references that
our curators use both to update the HbVar database con-
tent with novel variants and also to rectify data errors and
inconsistencies in existing variants.
THE NEW HbVar HOME PAGE
In order to better capture the data content, interrelated
databases and recent updates and user statistics, the HbVar
home page has been completely rebuilt. Firstly, the HbVar
logo has been redesigned to capture the original concept as
well as the Hb molecule notion in a more vibrant manner.
Secondly, the query the database functionality now occu-
pies a more central arrangement in the database to facilitate
activity by the end-user, compared to the previous situation.
Also, we included, in a tabular format, links to important
HbVar functionalities and features that are grouped in dif-
ferent rows in the table, such as:
a) the main HbVar functionalities, e.g. the summary of
mutation categories, query of compound heterozygotes
phenotype (see next paragraph), most recent updates
and frequently asked questions,
b) interrelation with other databases and resources, such
as FINDbase [http://www.findbase.org; (9)], the Lei-
den Open-Access Variation database [LOVD; http://
www.lovd.nl; (10)], dbSNP [https://www.ncbi.nlm.nih.
gov/snp; (11)] and the Penn State Genome Browser,
which is a mirror of the UCSC Genome Browser [https://
genome.ucsc.edu; (12)] customized to present data from
HbVar and other resources.
c) auxiliary information, such as the SNP coordinate con-
verter (see below), reference sequences, and a widely
used chart with mass differences resulting from amino
acid substitutions.
HbVar curators and contact information are provided at
the end of the new HbVar home page.
CLINICALLY RELEVANT QUERY PAGE UPGRADES
HbVar database has been considered a beneficial resource in
hemoglobin research since its establishment. As such, since
its last update, we opted to focus on clinically relevant up-
dates that would also make HbVar more useful to the clini-
cal community as well. Below, we describe two new features
that aim to help clinicians in better exploiting the wealth
of information available in HbVar. Both features are self-
explanatory with a brief description at the top of each query
window to facilitate the user.
Compound heterozygotes phenotype
Given the many genomic variants that yield different Hb
variants and thalassemia mutations, and most of them in
high allelic frequencies (6,9), there are often compound het-
erozygous cases that have different clinical features and lab-
oratory findings (13). Knowing the specific clinical features
of a combination of certain variants is crucial to establish
accurate diagnosis. For example, a common misdiagnosis
can be the combination of an HBB and an HBD gene vari-
ant that leads to normal HbA2 levels. The normal levels of
HbA2 means that these cases can easily escape the attention
of the physician but identifying them can be of utmost im-
portance especially in the case of prenatal diagnosis.
Therefore, we developed a tool to allow the HbVar users
from the clinical community to explore the clinical features
associated with combinations of globin gene alleles in com-
pound heterozygotes (a total of 309 entries of the database).
The compound heterozygotes phenotype tool (available at
http://globin.bx.psu.edu/cgi-bin/hbvar/hematable) includes
a large menu of clinical features from which the user can
select by ticking on the respective boxes (Figure 1). The se-
lected features will be included as columns in the subsequent
table generated by clicking on the ‘Select columns’ button.
The first two columns of the table include the globin gene
alleles combination for all 309 HbVar entries with informa-
tion for compound heterozygotes. The menu at the left side
of the screen includes filters that allows the user to narrow
down their query, the top one of which is the associated vari-
ant with the number of entries for this variant in brackets.
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Figure 1. The new compound heterozygotes phenotype tool of HbVar. A user can select the desired columns for the table output display from a wide variety
of options, according to the available HbVar data. The count of the number of rows that have data in each column is provided in brackets after each column
name (A). Upon selection of the columns, a table is generated and the user can narrow down his search by selecting the data from the filters at the left side
of the page (B).
the associated allele, where the query returns 38 results and
explore the clinical features that he has previously selected
in the table output. Each HbVar entry is a hyperlink that
takes the user to the respective HbVar entry page (Figure
1). The query output can be also exported in a .csv file for-
mat. Lastly, the user can alter the composition of the table
by selecting new columns by clicking on the button at the
top left corner of the page.
SNP coordinates converter
With the different numbering systems to determine a ge-
nomic position, there is often ambiguity as to the position
of a specific variant, especially among clinicians who of-
ten need urgently to assess clinical information of a spe-
cific variant. We have therefore developed a tool that pro-
vides this positional information and specifically converts
the genomic position provided in the common number sys-
tem to the various other systems, such as the official Human
Genome Organization (HUGO) genomic DNA-based de-
scription, the Human Genome Variation Society (HGVS)
coding DNA reference sequence, the DNA-based descrip-
tion using the GenBank reference sequences NG 000007.3
and NG 000006.1 and lastly, the common protein-based de-
scription. This tool is available at http://globin.bx.psu.edu/
cgi-bin/hbvar/coorSeqCheck.
In the demo query available in Figure 2, the user can se-
lect a given position or range for a specific globin chain (in
this case the range between −50 and +50 for the delta globin
chain, using the common DNA-based description. By click-
ing on the ‘Submit’ button, the query returns 12 HbVar en-
tries and 11 dbSNP entries, from the PSU Genome browser,
along with the synonyms of these genomic positions in all
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Figure 2. The new SNP coordinate converter tool. This tool looks up SNPs based on their position in the DNA or protein that can be given using various
numbering systems (see text). The result includes conversion of the position or range to other numbering systems in the list as well as checking HbVar and
dbSNP for entries at this position or range, respectively. It also provides a link to a genome browser to view the position with other annotations.
DATABASE ACCESS
Since their launch in January 2001, the HbVar database
and associated resources at the Globin Gene Server [http:
//globin.bx.psu.edu], such as the online Syllabi, are regu-
larly used worldwide. Also, HbVar is very frequently ac-
cessed by Facebook and mobile devices. Users frequently
contact the curators and the rest of the HbVar team mem-
bers in order to submit new hemoglobin variants and/or
thalassemia mutations, report missing information for ex-
isting mutants, identify inconsistencies and/or erroneous
entries, and even propose collaborative projects related to
HbVar data records.
Since its last update, and as seen in the ‘User statistics’
page that is now available (http://globin.bx.psu.edu/hbvar/
usage graphs.html), the number of annual users now ex-
ceeds 15000 for the query page and 8000 for the Summary
page (based on unique IP addresses). These figures show the
utility of HbVar for the globin research community.
FUTURE PROSPECTS
HbVar has become, since its inception and first launch,
a key data resource for information about DNA variants
leading to hemoglobinopathies and is still considered one of
the most important LSDBs from the various existing ones.
Key factors that have contributed to its broad adoption and
success are (a) its constant data update and improvements,
mostly driven by the long-term devotion and enthusiasm
of the data curators and other researchers involved in this
project, coming both from Europe and the US, (b) its dy-
namic data querying and visualization tools, in conjunc-
tion with the UCSC and PSU genome browsers, that are
constantly being upgraded to become more user friendly
and (c) its interrelation with other stable and well-respected
international databases. All these features allowed HbVar
to maintain a positive impact on the research community
and also allowed to attract funding on a continuous basis,
dedicated or related to other projects. This is particularly
important for keeping HbVar operational, in an environ-
ment where dedicated funding opportunities for database
development and curation are often very hard to secure,
frequently resulting in the discontinuation of many useful
databases.
In order to ensure continuous HbVar data enrichment,
we plan to implement a broader data searching strategy
that includes text-mining tools and other electronic search
procedures. This will complement the already existing tight
links to the scientific journal Hemoglobin and also other re-
sources such as the Human Gene Mutation database (www.
hgmd.org.uk; (14)), next to existing databases with which
HbVar has already existing bidirectional links (7,8).
The recent emphasis that HbVar has given to expand
its impact also among clinicians apart from researchers in-
volved in globin research highlights its potential to make
an impact in the clinical globin community, as well. In par-
ticular, HbVar can constitute a focal point for genotype
and phenotype data collection from a very large number of
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wide. Similar to the CFTR2 project (www.cftr2.org; (15),
such long-term effort would entail a thorough genotype
and clinical phenotype data contribution, based on the al-
ready well-documented microattribution approach (16,17),
allowing the identification of rare variants associated with
disease. In these individuals, 159 CFTR gene variants had
an allele frequency of 0.01%. These variants were evalu-
ated for both clinical severity and functional consequence,
with 127 (80%) meeting both clinical and functional criteria
consistent with disease. Assessment of disease penetrance
in 2,188 fathers of individuals with cystic fibrosis enabled
assignment of 12 of the remaining 32 variants as neutral,
whereas the other 20 variants remained of indeterminate ef-
fect. This study illustrates that sourcing data directly from
well-phenotyped subjects can address the gap in our ability
to interpret clinically relevant genomic variation.
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